CardioExchange Archive

September 1st, 2013

A Disruptive TASTE of the Future?

Larry Husten, PHD

Negative findings from a registry-based randomized trial of pre-PCI thrombus aspiration for STEMI patients

---

August 19th, 2013

Selections from Richard Lehman’s Literature Review: August 19th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include treating to risk, not to target; perceived job insecurity as a risk factor for incident CHD; ischemic preconditioning in patients undergoing CABG, and more.

---

May 17th, 2013

Instagram for Heart Attacks: iPhone App Speeds ECG Transmission to Hospital

Larry Husten, PHD

In the crucial early stages of a possible myocardial infarction (MI), EMTs on the scene now rely on slow and unreliable proprietary technology to transmit vital ECG data to physicians at a hospital for evaluation. But a new iPhone app using standard cell phone networks may help speed the process and, ultimately, cut delays in […]

---

April 16th, 2013

Selections from Richard Lehman’s Literature Review: April 16th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include fibrinolysis or primary PCI in STEMI, the effect of lower sodium intake on health, and the effect of increased potassium intake on CV risk factors and disease.

---

March 14th, 2013

Fibrinolysis Now or Primary PCI Later?

Frans Van de Werf, MD,PhD, Richard A. Lange, MD, MBA and L. David Hillis, MD

CardioExchange’s Rick Lange and David Hillis ask Frans Van de Werf, principal investigator for the STREAM study, about his study group’s findings and their implications for clinical practice. THE STUDY In the STREAM trial, investigators compared two treatment strategies in STEMI patients presenting early after symptom onset who were unable to undergo primary PCI within 1 hour: […]

---

March 10th, 2013

Fibrinolysis May Benefit Late-Arriving STEMI Patients

Larry Husten, PHD

For more of our ACC.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting, check out our Coverage Headquarters. Although primary PCI has emerged as the best treatment for STEMI, most patients don’t receive this treatment within the […]

---

December 17th, 2012

New Guidelines Define State-of-the-Art STEMI Care

Larry Husten, PHD

New guidelines published online today in Circulation and the Journal of the American College of Cardiology provide an efficient overview of the best treatments for STEMI patients. (Available for download are PDFs of the full version [64 pages] or the executive summary  [27 pages] of the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction.) “We’re looking to a future where more patients […]

---

October 29th, 2012

Selections from Richard Lehman’s Literature Review: October 29th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include CV risk factors and peripheral artery disease in men, radiofrequency ablation in paroxysmal AF, CPR duration and survival after in-hospital cardiac arrest, an everolimus-eluting stent vs. a bare-metal stent in STEMI, job strain and CHD, and more.

---

May 8th, 2012

Selections from Richard Lehman’s Literature Review: Week of May 7th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include a comparison of abciximab and manual aspiration thrombectomy in STEMI, the quality of U.S. clinical trials, 2-year data on PARTNER, TAVR in inoperable decompensating stenosis, clopidogrel genetic testing, and strategies to reduce MI mortality.

---

November 30th, 2011

Should FedEx Be in Charge of Primary PCI?

Richard A. Lange, MD, MBA and L. David Hillis, MD

Federal Express built its business on being a leader in transportation and delivering on time.  Perhaps the results of primary PCI in the U.S. would be better if FedEx ran the program. In patients with acute MI who must be transferred to another hospital for primary PCI, experts agree that the door-in to door-out (so called, […]

---